The Global Erectile Dysfunction Devices Market Size is valued at 1.69 billion in 2023 and is predicted to reach 3.62 billion by the year 2031 at a 10.12% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The growing prevalence of prostate cancer and other underlying health conditions are driving the erectile dysfunction market.
- Erectile dysfunction devices offer a non-invasive, drug-free alternative, appealing to patients seeking convenience and discretion, thus driving market growth.
- North America dominated the market and accounted for a global revenue share in 2023.
- Low awareness regarding prostate health among men poses a challenge for the erectile dysfunction market.
Patients with erectile dysfunction initially choose non-surgical alternatives such as injections, oral phosphodiesterase type-5 inhibitors (Viagra, Cialis, and others), suppositories, and penile pumps. The most popular choice for men seeking treatment for erectile dysfunction, however, is a penile implant if a patient does not respond to any of the aforementioned treatments.
According to the Cleveland Clinic, a non-profit academic medical centre with headquarters in Ohio, the United States, about 20,000 American males choose to have a penile implant each year. In the United States, penile implants are a common treatment choice, which is expected to spur market expansion over the upcoming years. Numerous awareness programmes focusing on the treatment of erectile dysfunction must be launched due to the condition's increased prevalence. Many companies, including Pfizer, are focusing on starting erectile dysfunction awareness programmes.
European impotence awareness campaigns and unbranded erectile dysfunction awareness campaigns aimed towards younger men are a couple of notable examples. For instance, in the United States, February 14 is recognised as National Impotence Day, on which the government and healthcare professionals raise public awareness of erectile dysfunction, its causes, and the range of treatment options available. They also pay attention to the various forms of erectile dysfunction and how it affects mental health.
Competitive Landscape:
Some of the Erectile Dysfunction Devices market players are:
- Boston Scientific Corporation
- Coloplast Group
- Rigicon, Inc.
- Promedon Gmbh
- Zephyr Surgical Implants
- Owen Mumford Ltd.
- Augusta Medical Systems Llc
- Shenzhen Huikang Medical Apparatus Co., Ltd.
- Zimmer Medizinsysteme Gmbh
- Medispec Ltd.
- Mts Medical Ug
- Novamedtek
- Storz Medical Ag
- The Elator
- Timm Medical
- Ohh-Med Medical Ltd.
- Comphya Sa
- Direxgroup
- Advin Health Care
- Giddy
- Global Life Technologies Ltd.
Market Segmentation:
The Erectile Dysfunction Devices market is segmented on the basis of treatment type, approach, and end user. Treatment type segment includes Shockwave Therapy Devices, Penile Implants, Vacuum Therapy Devices, and Others. Approach segments include Invasive and Non-invasive implants. End user segment includes Hospitals & Clinics, Ambulatory Surgery Centers, Pharmacies, and Others.
Based On Treatment Type, The Penile Implant Segment Is Accounted As A Major Contributor In The Erectile Dysfunction Devices Market
The penile implant category is expected to hold a major share of the global Erectile Dysfunction Devices market. Vacuum constriction devices, penile implants, shockwave therapy, and other device types are the main segments of the worldwide erectile dysfunction devices market. The market category expected to experience the highest growth rate is shockwave therapy. The non-invasive nature of the procedure, the absence of tablets or other pharmaceuticals, the expansion of companies making shockwave devices, and the rise of research into the use of shockwave therapy for the treatment of erectile dysfunction are expected to notice favourable market growth during the forecast period.
The Ambulatory Surgery Centers Segment Witnessed Growth At A Rapid Rate
Due to a number of factors, the ambulatory surgical centres (ASCs) sector is anticipated to experience the most noteworthy growth in the market for erectile dysfunction devices. First off, ASCs offer a practical and affordable alternative for outpatient operations, such as the installation of devices for erectile dysfunction. They provide a welcoming and specialised setting that is furnished with the tools and qualified medical personnel required to carry out these treatments. Second, the demand for procedures carried out in ASCs is fueled by patients and healthcare professionals' growing desire for minimally invasive therapies.
In addition to improving patient happiness, this section enables shorter hospital stays, fewer post-operative problems, and quicker recovery times. This area of the market for erectile dysfunction products is also growing due to the growing healthcare infrastructure and the increase in ASCs around the world.
In The Region, The North America Erectile Dysfunction Devices Market Holds A Significant Revenue Share
The erectile dysfunction devices market is expected to be dominated by the North American region for a number of reasons. Due to reasons including an ageing population and concerns with lifestyle, erectile dysfunction is pervasive in North America. This generates a sizable patient pool and increases the need for erectile dysfunction devices in the area. Second, the region has a state-of-the-art healthcare infrastructure, cutting-edge technology, and an advantageous reimbursement system that encourages the adoption of these devices.
The dominance of the North American segment in the erectile dysfunction devices market is also attributed to the existence of significant market participants, intensive research and development efforts, and a strong focus on men's health. Increased understanding and acceptance of erectile dysfunction as a curable ailment further add fuel to the market. Furthermore, the Asia Pacific region remains the fastest-growing market.
Recent Developments:
- In Nov 2023, Boston Scientific has received FDA approval for the Tenacio pump component of the AMS 700 inflatable penile prosthesis (IPP). The AMS 700 IPP provides a therapeutic alternative for individuals suffering from erectile dysfunction.
- In September 2023, Ohh-Med Medical established a presence in the UK, introducing a nonpharmaceutical treatment option for erectile dysfunction, thus broadening accessibility to the Vertica medical device.
Erectile Dysfunction Devices Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 1.69 Bn |
|
Revenue Forecast In 2031 |
USD 3.62 Bn |
|
Growth Rate CAGR |
CAGR of 10.12% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn, volume (number of units) and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Treatment Type, Approach, And End User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz Medical AG, Promedon, The Elator, Timm Medical, and Silimed |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
